Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II

Synapse

Volumn 63, Issue 8, 2009, Pages 625-635

  Han, Liqun ^a   Picker, Jonathan D ^a   Schaevitz, Laura R ^b   Tsai, Guochuan ^c   Feng, Jiamin ^a   Jiang, Zhichun ^c   Chu, Hillary C ^b   Basu, Alo C ^a   Berger Sweeney, Joanne ^b   Coyle, Joseph T ^a  

^a MCLEAN HOSPITAL   (United States)

^b WELLESLEY COLLEGE   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Glutamate; Glutamate carboxypeptidase II; Knockout mice; N acetyl aspartyl glutamate (NAAG); N methyl D aspartate receptor (NMDAR); Schizophrenia

Indexed keywords

CRE RECOMBINASE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMIC ACID; METABOTROPIC RECEPTOR 3; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EXON; GENE INSERTION; HETEROZYGOSITY; HYDROLYSIS; LETHALITY; LOCOMOTION; LOXP SITE; MALE; MOUSE; MUTANT; MUTATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; SPATIAL MEMORY; WORKING MEMORY;

ACOUSTIC STIMULATION; ANIMALS; BEHAVIOR, ANIMAL; EXONS; GENE EXPRESSION; GLUTAMATE CARBOXYPEPTIDASE II; HETEROZYGOTE; INTERPERSONAL RELATIONS; MEMORY; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION; PHENOTYPE; RECEPTORS, METABOTROPIC GLUTAMATE; SENSORY GATING; SPACE PERCEPTION;

EID: 67650439269     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20649     Document Type: Article

References (57)

1. Aubert L, Reiss D, Ouagazzal AM. 2006. Auditory and visual prepulse inhibition in mice: Parametric analysis and strain comparisons. Genes Brain Behav 5:423-431.
2. Bacich DJ, Ramadan E, O'Keefe DS, Bukhari N, Wegorzewska I, Ojeifo O, Olszewski R, Wrenn CC, Bzdega T, Wroblewska B, Heston WD, Neale JH. 2002. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate. J Neurochem 83:20-29.
3. Bacich DJ, Wozniak KM, Lu XC, O'Keefe DS, Callizot N, Heston WD, Slusher BS. 2005. Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury. J Neurochem 95:314-323.
4. Basu AC, Tsai GE, Ma CL, Ehmsen JT, Mustafa AK, Han L, Jiang ZI, Benneyworth MA, Froimowitz MP, Lange N, Snydre SH, Bergeron R, Coyle JT. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (in press).
5. Berger UV, Carter RE, Coyle JT. 1995. The immunocytochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase, and the NMDAR-1 receptor at a vertebrate neuromuscular junction. Neuroscience 64:847-850.
6. Berger UV, Luthi-Carter R, Passani LA, Elkabes S, Black I, Konradi C, Coyle JT. 1999. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol 415: 52-64.
7. Berger-Sweeney J, Arnold A, Gabeau D, Mills J. 1995. Sex differences in learning and memory in mice: Effects of sequence of testing and cholinergic blockade. Behav Neurosci 109:859-873.
8. Bergeron R, Coyle JT, Tsai G, Greene RW. 2005. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology 30:7-16.
9. Bergeron R, Imamura Y, Frangioni JV, Greene RW, Coyle JT. 2007. Endogenous N-acetylaspartylglutamate reduced NMDA receptordependent current neurotransmission in the CA1 area of the hippocampus. J Neurochem 100:346-357.
10. Bischofberger J, Schild D. 1996. Glutamate and N-acetylaspartylglutamate block HVA calcium currents in frog olfactory bulb interneurons via an mGluR2/3-like receptor. J Neurophysiol 76:2089-2092.
11. Braff DL, Geyer MA, Swerdlow NR. 2001. Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234-258.
12. Bzdega T, Crowe SL, Ramadan ER, Sciarretta KH, Olszewski RT, Ojeifo OA, Rafalski VA, Wroblewska B, Neale JH. 2004. The cloning and characterization of a second brain enzyme with NAAG peptidase activity. J Neurochem 89:627-635.
13. Carter RE, Coyle JT. 2004. Glutamate carboxypeptidase II. In: Barrett AJ, Rawlings ND, Woessner JF, editors. Handbook of Proteolytic Enzymes, 2nd ed. Academic Press, New York. Vol. 290, p 960-963.
14. Carter RE, Feldman AR, Coyle JT. 1996. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci USA 93: 749-753.
15. Cassidy M, Neale JH. 1993. Localization and transport of N-acetylaspartylglutamate in cells of whole murine brain in primary culture. J Neurochem 60:1631-1638.
16. st ed. Hoboken: John Wiley & Sons.
17. Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH. 2004. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 153:507-519.
18. Enomoto T, Noda Y, Nabeshima T. 2007. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis. Methods Find Exp Clin Pharmacol 29:291-301.
19. Fredriksson A, Archer T, Alm H, Gordh T, Eriksson P. 2004. Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav Brain Res 153:367-376.
20. Frick KM, Burlingame LA, Arters JA, Berger-Sweeney J. 2000. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience 95:293-307.
21. Frondoza CG, Logan S, Forloni G, Coyle JT. 1990. Production and characterization of monoclonal antibodies to N-acetyl-aspartyl-glutamate. J Histochem Cytochem 38:493-502.
22. Grunze HC, Rainnie DG, Hasselmo ME, Barkai E, Hearn EF, McCarley RW, Greene RW. 1996. NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 16:2034-2043.
23. Guilarte TR, Hammoud DA, McGlothan JL, Caffo BS, Foss CA, Kozikowski AP, Pomper MG. 2008. Dysregulation of glutamate carboxypeptidase II in psychiatric disease. Schizophr Res 99:324-332.
24. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746-4751.
25. Halsted CH, Ling EH, Luthi-Carter R, Villanueva JA, Gardner JM, Coyle JT. 1998. Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem 273:20417-20424.
26. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andradé M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A. 2007. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 104:14501-14506.
27. Lalonde R, Kim HD, Maxwell JA, Fukuchi K. 2005. Exploratory activity and spatial learning in 12-month-old APP(695)SWE/ co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett 390: 87-92.
28. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA. 2008. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31:234-242.
29. Moffett JR, Cassidy M, Namboodiri MA. 1989. Selective distribution of N-acetylaspartylglutamate immunoreactivity in the extrapyramidal system of the rat. Brain Res 494:255-266.
30. Moffett JR, Namboodiri MA. 1995. Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. J Neurocytol 24:409-433.
31. Moffett JR, Namboodiri MA, Neale JH. 1993. Enhanced carbodiimide fixation for immunohistochemistry: Application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J Histochem Cytochem 41:559-570.
32. Moffett JR, Palkovits M, Namboodiri A, Neale JH. 1994. Comparative distribution of N-acetylaspartylglutamate and GAD67 in the cerebellum and precerebellar nuclei of the rat utilizing enhanced carbodiimide fixation and immunohistochemistry. J Comp Neurol 347:598-618.
33. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. 1999. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
34. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN. 2004. Sociability and preference for social novelty in five inbred strains: An approach to assess autistic-like behavior in mice. Genes Brain Behav 3:287-302.
35. O'Keefe DS, Bacich DJ, Heston WD. 2004. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene. Prostate 58:200-210.
36. Passani LA, Vonsattel JP, Coyle JT. 1997. Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease. Brain Res 772:9-22.
37. Renno WM, Lee JH, Beitz AJ. 1997. Light and electron microscopic immunohistochemical localization of N-acetylaspartylglutamate (NAAG) in the olivocerebellar pathway of the rat. Synapse 26: 140-154.
38. Robinson MB, Blakely RD, Couto R, Coyle JT. 1987. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J Biol Chem 262:14498-14506.
39. Rung JP, Carlsson A, Rydén Markinhuhta K, Carlsson ML. 2005. MK-801 induced social withdrawal in rats; A model for negative symptoms of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:827-832.
40. Sácha P, Zámecník J, Barinka C, Hlouchová K, Vícha A, Mlcochová P, Hilgert I, Eckschlager T, Konvalinka J. 2007. Expression of glutamate carboxypeptidase II in human brain. Neuroscience 144:1361-1372.
41. Shafizadeh TB, Halsted CH. 2007. gamma-Glutamyl hydrolase, not glutamate carboxypeptidase II, hydrolyzes dietary folate in rat small intestine. J Nutr 137:1149-1153.
42. Slusher BS, Robinson MB, Tsai G, Simmons ML, Richards SS, Coyle JT. 1990. Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization. J Biol Chem 265:21297-21301.
43. Slusher BS, Tsai G, Yoo G, Coyle JT. 1992. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Comp Neurol 315:217-229.
44. Slusher BS, Vornov JJ, Thomas AG, Hurn PD, Harukuni I, Bhardwaj A, Traystman RJ, Robinson MB, Britton P, Lu XC, Tortella FC, Wozniak KM, Yudkoff M, Potter BM, Jackson PF. 1999. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med 5:1396-1402.
45. Speno HS, Luthi-Carter R, Macias WL, Valentine SL, Joshi AR, Coyle JT. 1999. Site-directed mutagenesis of predicted active site residues in glutamate carboxypeptidase II. Mol Pharmacol 55: 179-185.
46. Stauch BL, Robinson MB, Forloni G, Tsai G, Coyle JT. 1989. The effects of N-acetylated alpha-linked acidic dipeptidase (NAALADase) inhibitors on [3H]NAAG catabolism in vivo. Neurosci Lett 100:295-300.
47. Swerdlow NR, Geyer MA. 1998. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24:285-301.
48. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. 2008. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 199:331-388.
49. Tkachev D, Mimmack ML, Huffaker SJ, Ryan M, Bahn S. 2007. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. Int J Neuropsychopharmacol 10:557-563.
50. Tsai G, Forloni G, Robinson MB, Stauch BL, Coyle JT. 1988. Calcium-dependent evoked release of N-[3H]acetylaspartylglutamate from the optic pathway. J Neurochem 51:1956-1959.
51. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT. 1995. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829-886.
52. Tsai G, Slusher BS, Sim L, Coyle JT. 1993. Immunocytochemical distribution of N-acetylaspartylglutamate in the rat forebrain and glutamatergic pathways. J Chem Neuroanat 6:277-292.
53. Tsai G, Dunham KS, Drager U, Grier A, Anderson C, Collura J, Coyle JT. 2003. Early embryonic death of glutamate carboxypeptidase II (NAALADase) homozygous mutants. Synapse 50:285-292.
54. Williamson LC, Neale JH. 1988. Calcium-dependent release of N-acetylaspartylglutamate from retinal neurons upon depolarization. Brain Res 475:151-155.
55. Wroblewska B, Wroblewski JT, Pshenichkin S, Surin A, Sullivan SE, Neale JH. 1997. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J Neurochem 69: 174-181.
56. Zhong C, Zhao X, Sarva J, Kozikowski A, Neale JH, Lyeth BG. 2005. NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats. J Neurotrauma 22:266-276.
57. Zollinger M, Brauchli-Theotokis J, Gutteck-Amsler U, Do KQ, Streit P, Cuénod M. 1994. Release of N-acetylaspartylglutamate from slices of rat cerebellum, striatum, and spinal cord, and the effect of climbing fiber deprivation. J Neurochem 63:1133-1142.